The staff of Kexing Holding Biotechnology Co., Ltd. confirmed that the Corporal Crown Vaccine has been discontinued, and the company will no longer sell the coronary vaccine.
According to the Hong Kong Zhongtong News Agency on Wednesday (January 10), a document called the "Performance and Wage Plan for the Cross -Organization Project" was circulated on the Internet.Vibial technology company.
According to the document, the company's coronary vaccine has been discontinued, and there is currently no coronary vaccine product sales. Therefore, it was decided to stop issuing the performance salary of the crown project of existing employees from January.
Beijing Kexingzhong Vitamin Technology Company is a subsidiary of Kexing Holding Biotechnology Co., Ltd.
According to Jixu News, the staff of the product consulting hotline of Kexing Holdings Biotechnology Co., Ltd. confirmed that Kexing's coronary vaccine has been discontinued.Essence
It is reported that there are still many vaccines for new strains in various parts of China.
The Beijing Centers for Disease Control and Prevention said on December 11 last year that the main popular strains of coronary virus are XBB and its sub -branch.China already has a number of XBB vaccines approved for emergency use.
